These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38695720)

  • 1. The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination.
    Karal BN; Özdemir YE; Karayağmurlu A
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):427-429. PubMed ID: 38695720
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
    Schmidt-Kraepelin C; Feyerabend S; Engelke C; Riesbeck M; Meisenzahl-Lechner E; Gaebel W; Verde PE; Kolbe H; Correll CU; Leucht S; Heres S; Kluge M; Makiol C; Neff A; Lange C; Englisch S; Zink M; Langguth B; Poeppl T; Reske D; Gouzoulis-Mayfrank E; Gründer G; Hasan A; Brockhaus-Dumke A; Jäger M; Baumgärtner J; Wobrock T; Cordes J
    Eur Arch Psychiatry Clin Neurosci; 2020 Feb; 270(1):83-94. PubMed ID: 31486890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cost-effectiveness of amisulpride and olanzapine in the treatment of schizophrenia in China.
    Yi ZM; Men P; Qu S; Li C; Yu X; Zhai S
    Expert Rev Pharmacoecon Outcomes Res; 2020 Jun; 20(3):313-320. PubMed ID: 32293194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amisulpride, a one-of-a-kind and highly efficacious antipsychotic agent in the treatment of first-episode psychosis].
    Luykx JJ; Kraats GV; van Ojen R
    Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31647624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study.
    Galuba V; Cordes J; Feyerabend S; Riesbeck M; Meisenzahl-Lechner E; Correll CU; Kluge M; Neff A; Zink M; Langguth B; Reske D; Gründer G; Hasan A; Brockhaus-Dumke A; Jäger M; Baumgärtner J; Leucht S; Schmidt-Kraepelin C;
    Schizophr Res; 2024 Aug; 270():383-391. PubMed ID: 38986385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
    Kahn RS; Winter van Rossum I; Leucht S; McGuire P; Lewis SW; Leboyer M; Arango C; Dazzan P; Drake R; Heres S; Díaz-Caneja CM; Rujescu D; Weiser M; Galderisi S; Glenthøj B; Eijkemans MJC; Fleischhacker WW; Kapur S; Sommer IE;
    Lancet Psychiatry; 2018 Oct; 5(10):797-807. PubMed ID: 30115598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
    Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betahistine-Associated Weight Loss and Improved Cognitive and Negative Symptoms: Domain in Early-Onset Schizophrenia.
    Naguy A; AlShalabi SR; AlKhadhari S
    Am J Ther; 2019; 26(6):e790-e792. PubMed ID: 31206362
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.
    Men P; Yi Z; Li C; Qu S; Xiong T; Yu X; Zhai S
    BMC Psychiatry; 2018 Sep; 18(1):286. PubMed ID: 30185173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
    Bhowmick S; Hazra A; Ghosh M
    Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report of Clozapine-Associated Stuttering and Amisulpride-Associated Stuttering and Seizure in an Adult on Concurrent Fluoxetine Therapy.
    Mathur R; Singh J; Sood M
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):330-332. PubMed ID: 33675589
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential Effectiveness of Atypical Antipsychotics on Hallucinations: A Pragmatic Randomized Controlled Trial.
    Sinkeviciute I; Hugdahl K; Bartz-Johannessen C; Kroken RA; Løberg EM; Kjelby E; Rettenbacher MA; Joa I; Reitan SK; Alisauskiene R; Fathian F; Johnsen E
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):389-396. PubMed ID: 33938520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine.
    Drosos P; Johnsen E; Bartz-Johannessen CA; Larsen TK; Reitan SK; Rettenbacher M; Kroken RA
    Schizophr Res; 2024 Sep; 271():9-18. PubMed ID: 39002529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study.
    Alisauskiene R; Johnsen E; Gjestad R; Kroken RA; Kjelby E; Sinkeviciute I; Fathian F; Joa I; Reitan SK; Rettenbacher M; Løberg EM
    Gen Hosp Psychiatry; 2023; 83():185-193. PubMed ID: 37269769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders: A Secondary Outcome Analysis of a Pragmatic, Randomized Trial (BeSt InTro).
    Kjelby E; Gjestad R; Fathian F; Sinkeviciute I; Alisauskiene R; Anda L; Løberg EM; Reitan SK; Joa I; Larsen TK; Rettenbacher M; Berle JØ; Fasmer OB; Kroken RA; Johnsen E
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):246-258. PubMed ID: 37083542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
    Ruiz-Doblado S; Plasencia-García de Diego B; Perea-Pérez R; Jiménez-Gonzalo F
    Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
    [No Abstract]   [Full Text] [Related]  

  • 18. Amisulpride versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Silveira da Mota Neto JI; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD006624. PubMed ID: 20091599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic Weight Loss Following Addition of Aripiprazole to Olanzapine in a Patient With Treatment-resistant Schizophrenia: A Case Report.
    Boland X; Chhabra P
    J Psychiatr Pract; 2019 Mar; 25(2):135-138. PubMed ID: 30849062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.